Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS. ISENTRESS® (raltegravir) film-coated tablets, for oral useISENTRESS® HD (raltegravir) film-coated tablets, for oral useISENTRESS® (raltegravir) chewable tablets, for oral useISENTRESS® (raltegravir) for oral suspensionInitial U.S. Approval: 2007
Medication labelWhy this: Advisory · dailymed-prescription
Adult Patients: ISENTRESS® and ISENTRESS® HD are indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection in adult patients. Pediatric Patients: ISENTRESS is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in pediatric patients weighing at least 2 kg. ISENTRESS HD is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in pediatric patients weighing at least 40 kg.
- generic_name
- raltegravir
- product_names
- RALTEGRAVIR
- ndc
- 53002-1686, 0006-0227, 53002-1686-5, 53002-1686-1, 53002-1686-6, 53002-1686-4
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en